Study of Magrolimab Combination Therapy in Patients With Non-Surgically Removable Locally Advanced or Metastatic Triple-Negative Breast Cancer
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Triple-Negative Breast Cancer
Interventions: DRUG: Magrolimab|DRUG: Nab-Paclitaxel|DRUG: Paclitaxel|DRUG: Sacituzumab Govitecan-hziy
Sponsor: Gilead Sciences